Dan Kracov is a partner in Arnold & Porter’s Washington, D.C. office, where he chairs the firm’s FDA & Healthcare practice. He helps large manufacturing companies, trade associations and early-stage ventures negotiate challenges relating to the development, manufacturing, approval and promotion of drugs, biologics, medical devices and diagnostics.
In addition to day-to-day regulatory counseling, he regularly handles high stakes investigations and enforcement proceedings, the development of global compliance programs, and due diligence in financings, mergers and acquisitions. He has a widely recognized expertise in biomedical product-related public policy matters, including Congressional investigations and FDA-related legislation.
Mr. Kracov received his JD from the University of Virginia School of Law and his BA, magna cum laude, from the University of Maryland.